Compare EDD & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EDD | ACB |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance Companies | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 345.5M | 260.2M |
| IPO Year | N/A | N/A |
| Metric | EDD | ACB |
|---|---|---|
| Price | $5.51 | $5.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 254.3K | ★ 1.3M |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 7.52% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $263,570,704.00 |
| Revenue This Year | N/A | $11.82 |
| Revenue Next Year | N/A | $8.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 23.89 |
| 52 Week Low | $4.22 | $3.42 |
| 52 Week High | $4.95 | $6.91 |
| Indicator | EDD | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 53.91 | 69.54 |
| Support Level | $5.48 | $4.43 |
| Resistance Level | $5.69 | $4.69 |
| Average True Range (ATR) | 0.07 | 0.20 |
| MACD | -0.00 | 0.09 |
| Stochastic Oscillator | 51.35 | 92.34 |
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.
Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.